Related Experiment Video
Updated: Jul 12, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
[Recent treatment perspectives in lipidology]
A J Scheen1, R Radermecker, J De Flines
1Université de Liège.
Revue Medicale De Liege
|August 30, 2007
Summary
Statins are crucial for cardiovascular disease prevention, offering protection regardless of baseline cholesterol levels. Treatment intensity should focus on individual cardiovascular risk, not just cholesterol numbers.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Lipidology
Context:
- Clinical lipidology has evolved significantly since the 4S study in 1994.
- Statins are now central to managing cardiovascular diseases.
- Recent findings present a dual perspective on cholesterol management.
Purpose:
- To review the current understanding of statin therapy in cardiovascular disease prevention.
- To reconcile apparently conflicting data on cholesterol levels and cardiovascular risk.
- To provide guidance on optimizing lipid-lowering strategies.
Summary:
- Two key findings dominate recent lipidology: lower cholesterol correlates with reduced cardiovascular risk, and statins offer cardiovascular protection irrespective of baseline cholesterol, suggesting pleiotropic effects.
- Consequently, statin therapy should be guided by individual cardiovascular risk rather than solely by cholesterol levels.
- Adjunctive therapies like ezetimibe or fenofibrate are recommended for patients not at target LDL or with abnormal triglyceride/HDL levels.
Impact:
- This approach emphasizes personalized cardiovascular risk management.
- It supports the intensified use of statins and combination therapies for optimal patient outcomes.
- Future research focuses on novel therapies, particularly for low HDL cholesterol.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...